» Articles » PMID: 17257616

Dimer Dissociation and Unfolding Mechanism of Coagulation Factor XI Apple 4 Domain: Spectroscopic and Mutational Analysis

Overview
Journal J Mol Biol
Publisher Elsevier
Date 2007 Jan 30
PMID 17257616
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The blood coagulation protein factor XI (FXI) consists of a pair of disulfide-linked chains each containing four apple domains and a catalytic domain. The apple 4 domain (A4; F272-E362) mediates non-covalent homodimer formation even when the cysteine involved in an intersubunit disulfide is mutated to serine (C321S). To understand the role of non-covalent interactions stabilizing the FXI dimer, equilibrium unfolding of wild-type A4 and its C321S variant was monitored by circular dichroism, intrinsic tyrosine fluorescence and dynamic light scattering measurements as a function of guanidine hydrochloride concentration. Global analysis of the unimolecular unfolding transition of wild-type A4 revealed a partially unfolded equilibrium intermediate at low to moderate denaturant concentrations. The optically detected equilibrium of C321S A4 also fits best to a three-state model in which the native dimer unfolds via a monomeric intermediate state. Dimer dissociation is characterized by a dissociation constant, K(d), of approximately 90 nM (in terms of monomer), which is in agreement with the dissociation constant measured independently using fluorescence anisotropy. The results imply that FXI folding occurs via a monomeric equilibrium intermediate. This observation sheds light on the effect of certain naturally occurring mutations, such as F283L, which lead to intracellular accumulation of non-native forms of FXI. To investigate the structural and energetic consequences of the F283L mutation, which perturbs a cluster of aromatic side-chains within the core of the A4 monomer, it was introduced into the dissociable dimer, C321S A4. NMR chemical shift analysis confirmed that the mutant can assume a native-like dimeric structure. However, equilibrium unfolding measurements show that the mutation causes a fourfold increase in the K(d) value for dissociation of the native dimer and a 1 kcal/mol stabilization of the monomer, resulting in a highly populated intermediate. Since the F283 side-chain does not directly participate in the dimer interface, we propose that the F283L mutation leads to increased dimer dissociation by stabilizing a monomeric state with altered side-chain packing that is unfavorable for homodimer formation.

Citing Articles

Factor XI, a potential target for anticoagulation therapy for venous thromboembolism.

Li T, Liu J, Wu W Front Cardiovasc Med. 2022; 9:975767.

PMID: 36386334 PMC: 9659736. DOI: 10.3389/fcvm.2022.975767.


An update on factor XI structure and function.

Mohammed B, Matafonov A, Ivanov I, Sun M, Cheng Q, Dickeson S Thromb Res. 2017; 161:94-105.

PMID: 29223926 PMC: 5776729. DOI: 10.1016/j.thromres.2017.10.008.


Destabilization of the dimer interface is a common consequence of diverse ALS-associated mutations in metal free SOD1.

Broom H, Rumfeldt J, Vassall K, Meiering E Protein Sci. 2015; 24(12):2081-9.

PMID: 26362407 PMC: 4815230. DOI: 10.1002/pro.2803.


Chemical and thermal unfolding of a global staphylococcal virulence regulator with a flexible C-terminal end.

Mahapa A, Mandal S, Biswas A, Jana B, Polley S, Sau S PLoS One. 2015; 10(3):e0122168.

PMID: 25822635 PMC: 4379015. DOI: 10.1371/journal.pone.0122168.


LcrH, a class II chaperone from the type three secretion system, has a highly flexible native structure.

Singh S, Boyle A, Main E J Biol Chem. 2012; 288(6):4048-55.

PMID: 23233673 PMC: 3567656. DOI: 10.1074/jbc.M112.395889.


References
1.
Jameson D, Seifried S . Quantification of protein-protein interactions using fluorescence polarization. Methods. 1999; 19(2):222-33. DOI: 10.1006/meth.1999.0853. View

2.
Wolberg A, Morris D, Stafford D . Factor IX activation by factor XIa proceeds without release of a free intermediate. Biochemistry. 1997; 36(14):4074-9. DOI: 10.1021/bi962274y. View

3.
Kravtsov D, Monahan P, Gailani D . A classification system for cross-reactive material-negative factor XI deficiency. Blood. 2005; 105(12):4671-3. PMC: 1895004. DOI: 10.1182/blood-2004-05-1864. View

4.
Sinha D, Marcinkiewicz M, Lear J, Walsh P . Factor XIa dimer in the activation of factor IX. Biochemistry. 2005; 44(30):10416-22. DOI: 10.1021/bi050361x. View

5.
Saunders R, OConnell N, Lee C, Perry D, Perkins S . Factor XI deficiency database: an interactive web database of mutations, phenotypes, and structural analysis tools. Hum Mutat. 2005; 26(3):192-8. DOI: 10.1002/humu.20214. View